AllDocs -> cancers

Fox Chase Cancer Center 2001 Scientific Report Depletion of WHV Replication Intermediates Via a By-stander Effect in a Transgenic Mouse. Song, Zhou, d Mason, in collaboration with Jilbert, e Seeger, § Sigal, § Rall § Previous studies from us and others have revealed that clearance of transient hepatitis B virus (hepadnavirus) infections must initiate with a shut down of virus replication within infected cells. Moreover, experiments with HBV transgenic mice have shown that cytok- ines elaborated by the immune system can induce a rapid degradation of intermediates in hepadnavirus replication, effectively shutting down virus production, without producing any damage to the infected cell. For example, INF ? and TFN a , produced in response to infection of only a ...

EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 33, No. 4, 179-190, December 2001 Chronic liver injury, TGF- ß , and cancer D. Montgomery Bissell 1,2 1 University of California, San Francisco 2 Corresponding author: Fax, +1-415-476-0659; E-mail, dmbiss@itsa.ucsf.edu Accepted 19 November 2001 Abbreviations: ECM, extracellular metrix; HSC, hepatic stellate cell; HCC, hepatocellular carcinoma Abstract Cells termed myofibroblasts are prominent in the injury response of all epithelial tissues. They exhibit proliferation, migration, production of collagen and other extracellular matrix (ECM) molecules, and con- traction, all for containing the injury and closing the wound. When the injury is limited in time, the final stage of the repair involves a dismantling of the cel- lular apparatus and restoration of normal ...

P2 CANCER . BASIC ASPECTS 78 Obstructive Jaundice Results in Increased Liver Expression of Uncoupling Protein 2 and Intact Skeletal Muscle Glucose Metabolism in the Rat Bengt Isaksson 1 , Catarina Rippe 2 , Rusana Simonoska 1 , Jan-Erik Holm 1 , Ralf Segersvärd 1 , Jörgen Larsson 1 , Charlotte Erlanson-Albertsson 2 , Johan Permert 1 Arvid Wretlind Laboratory for Metabolic and Nutritional Research 1 , Department of Surgery, Karolinska Institute at Huddinge University Hospital, S-141 86 Stockholm, Sweden, Department of Medical Chemistry 2 , Lunds University Hospital, Lund, Sweden Background and Aims : A majority of patients with pancreatic cancer have obstructive jaundice and diabetes with skeletal muscle insulin ...

Liver Cancer Complementary Therapy: Nutritional Supplementation CancerOption.com offers extensive information outlining the complementary therapies used by cancer specialists and cancer clinics worldwide. These therapies were designed to work in conjunction with traditional treatment options in an effort to increase efficacy of current treatments, prevent reoccurrence and sustain remission. There is no "cure" for cancer ; however there are treatment options available today, which may increase life expectancy and life quality. If you have any questions regarding your treatment options, contact your Physician or Oncologist. To review the complete Liver Cancer Complementary Therapy, visit http://www.canceroption.com One-Month Suggested Supply: 1 - ImmuneOption™ (2 Kilo) or 4 ImmuneOption (300g) 1 - BETAGlucan CAOP™ 1 - ImmuneEssential ...

Liver Cancer Complementary Therapy: Suggested Supplementation If you have any questions regarding your treatment options, contact your Physician or Oncologist. To review the complete Liver Cancer Complementary Therapy, visit http://www.canceroption.com ImmuneOption 2 scoops, in water or juice, 3 times daily with meals (6 scoops total a day) BETAGlucan CAOP 1 capsule, 3 times daily, take 30 minutes before meals (3 capsules total a day) ImmuneEssential CAOP 3 drops, sublingual for 5 minutes, 7 times daily (Oral - refrigerate bottle) (21 drops total a day; use applicator) or ImmuneEssential CAOP 7 drops, 3 times daily on skin or afflicted areas (Topical – refrigerate bottle) (21 drops total a day; use applicator) FloraPlusOption ½ teaspoon, 1 time a day in pure water (refrigerate bottle) Vita-C Option ...

2000 Pancreas Cancer Deaths by ZIP Code 9 to 12 6 to 8 3 to 5 1 to 2 none Bexar County, Texas 2000 Liver Cancer Deaths by ZIP Code 6 to 8 3 to 5 1 to 2 none Bexar County, Texas 5 2.5 m i l e s 0 5 2 . 5 m i l e s 0 Page 1

Liver Cancer What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells often travel to other parts of the body where they begin to grow and replace normal tissue. This process, called metastasis, occurs as the cancer cells get into the bloodstream or lymph vessels of our ...

All-Ireland cancer statistics 1994-96 50 Liver and intrahepatic bile ducts 8. MALIGNANT CANCER OF THE LIVER AND INTRAHEPATIC BILE DUCTS (summary) ICD-O.2 C22 ICD-10 C22 ICD-9 155 Key facts • Average of 113 new cases per year, 1994-96: 43 cases in females, 70 in males. • Average of 192 deaths per year: 80 in females, 112 in males. • Age-standardised incidence and mortality rates about twice as high in males as in females. • 11th most common cause of cancer deaths in males, 12th in males. • Incidence rates in Northern Ireland (NI) about 130% higher for females, 50% for males, than the Republic (RoI). • Incidence rates well below EU 1995 averages. Summary statistics Table 8.1 Incidence 1994-96 Primary, malignant cancer of the liver and intrahepatic bile ducts is uncommon. ...

Basic Science Division 1 0 5 The Role of Hepatocyte Regeneration in the Clearance of Hepadnavirus Infections from the Liver . Zhu, Yamamoto, Saputelli, Aldrich, Mason, in collaboration with Cullen, b Litwin, § Furman, c Jilbert d Hepatitis B viruses cause chronic and pro- ductive infections of hepatocytes. New viral DNA is produced by reverse transcription, which occurs in the cytoplasm, but viral RNA is transcribed from a covalently closed circular form of viral DNA (cccDNA) that is only found in the nucleus. The goal of antiviral therapy is to eliminate not just the viral DNAs in the cyto- plasm, but also the cccDNA in the nucleus. Inhibitors of the hepatitis B virus DNA poly- merase block new viral DNA synthesis, so that these DNAs are quickly cleared from the cyto- plasm of the infected cell. ...

447 March Road Kanata, Ontario Canada K2K 1X8 Tel: 613 592-2790 NEWS RELEASE March 21, 2000 Inoperable Primary Liver Cancer Treatment Receives Humanitarian Device Exemption TheraSphere’s Microscopic Glass Beads Offer Alternative to Chemotherapy in Inoperable Cases Kanata, Ontario, Canada - MDS Nordion, a global leader in radioisotope technology, received authorization from the US Food and Drug Administration to market TheraSphere , a non-surgical outpatient therapy that uses microscopic glass beads to deliver radiation therapy to treat inoperable hepatocellular carcinoma (HCC), a liver cancer . This form of liver cancer is one of the most common tumours in the world, affecting up to 10 percent of the population in sub-Saharan Africa and Southeast Asia. 1 At present, the incidence of HCC in the US is low, but is expected ...

Bradfield; Mechanisms of Liver Carcinogenesis 18 UNIT V: Models of Liver Cancer , Non Genotoxic Carcinogens Assigned Reading: Pitot et al. (1996). Quantitation of multistage carcinogenesis in rat liver . Toxicologic Pathology. 24:119. 1) Not all carcinogens are genotoxic, (i.e., directly alkylate DNA and cause mutations). 2) Chemicals that enhance carcinogenic responses to genotoxic carcinogens are known as promoters. 3) Modeling HCC in rodents can be performed by monitoring the evolution of carcinogen induced enzyme altered foci. Non Genotoxic Carcinogens: Until now, we have been talking about carcinogens that act via direct/covalent modification of DNA (“alkylation”). We have talked about the early proposal that all carcinogens are mutagens. From the initial DNA alkylation studies and mutagenicity studies came the classification of mutagenic/alkylating ...

Bradfield; Mechanisms of Liver Carcinogenesis 1 Chris Bradfield, 262-2024 213 McArdle , Bradfield@oncology.wisc.edu Assignments: Each lecture summary sheet will have questions within the text that are bold and in italics. Please be prepared to answer these questions in class. In addition written short answers to these same questions will be due four times throughout the next few weeks. I will assign the exact dates in class depending on how fast we move through the material. Assigned Reading for unit I: These readings are meant to provide background. 1) Briefly review liver physiology before the first session (any physiology text will do). 2) Venook, AP (1994). Hepatocellular carcinoma: Too many options? J. Clin. Oncology. 12:1323. UNIT I: Liver Biology, Pathology and Cancer It is important to understand liver biology, pathology and cancer ...

University of Kentucky HealthCare Physician’s Practice Digest Issue 24 All too often, diagnoses of liver cancer or liver metastases carry a grim prognosis: 80 to 90 percent of cases are inoperable because of their size, number or location of liver lesions, and fewer than 10 percent of cases respond to chemo- therapy. Because of this, the five-year survival rate is less than ten percent. However, a new option now available at University of Kentucky Chandler Medical Center is inspiring new optimism for liver cancer patients across the state. UK surgeons are using radiofrequency ablation (RFA) to treat previously inoperable lesions. RFA is a technique that destroys liver tumors in situ by localized application of heat to produce coagulative necrosis. "For patients whose primary or meta- static disease is confined to the liver ...

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:YAvyro5jRhIJ:www.fccc.edu/docs/sci_report1999/Mason.pdf allintitle: liver cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Session: Open topics Epidemiology — 2, Sept. 13, 16:00 Multinational liver cancer case-control study in women H EINEMANN LAJ, G ARBE E ZEG Zentrum für Epidemiologie und Gesundheitsforschung Berlin, zeg@snafu.de Session: Open topics Epidemiology — 2, Sept. 13, 16:00 Introduction Many, but not all previous epidemiological studies indicated a greater risk of hepatocellular cancer (HCC) in women who have used combined oral contraceptives (OCs) for a long period of time.1 To estimate the risk of HCC for combined OC and specific formulations. Methods and Results European case-control study, which included 317 cases of hepatocellular cancer (HCC) in women under age 65, compared with 1,060 age-matched hospital and 719 population controls. The analysis was adjusted for important risk factors of HCC. The adjusted odds ratio (unconditional logistic ...

Duke Researchers Show How Infection Leads to Liver Cancer DURHAM, N.C. -- Hepatitis B and C infections slowly eat away at a person's liver , severely damaging liver function and greatly increasing the risk of liver cancer . Now researchers at Duke University Medical Center have discovered the hepatitis virus makes the liver into a cancer time bomb by converting the organ into billions of cancer -prone cells. The finding, published in the Sept. 16 issue of the Proceedings of the National Academy of Sciences, demonstrates that once a hepatitis infection takes hold in the liver , even apparently healthy cells have lost one of two copies of a protective tumor suppressor gene called M6P/IGF2R, making them highly vulnerable to further genetic damage. Without a working copy of this suppressor gene, cancerous cell growth can't be stopped. "This finding demonstrates that hepatitis infection somehow favors ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:X7djtEIAfbgJ:repository.ust.hk/retrieve/1252/210.pdf allintitle: liver cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

NYS NYC 05 Staten Isl 04 Queens 03 Brooklyn 02 Bronx 01 Manhattan 62 Yates * 61 Wyoming * 60 Westchester 59 Wayne * 58 Washington * 57 Warren * 56 Ulster 55 Tompkins * 54 Tioga * 53 Sullivan * 52 Suffolk 51 Steuben * 50 Seneca * 49 Schuyler * 48 Schoharie * 47 Schenectady * 46 Saratoga * 45 St Lawrence * 44 Rockland 43 Rensselaer * 42 Putnam * 41 Otsego * 40 Oswego * 39 Orleans * 38 Orange * 37 Ontario * 36 Onondaga 35 Oneida * 34 Niagara 33 Nassau 32 Montgomery * 31 Monroe 30 Madison * 29 Livingston * 28 Lewis * 27 Jefferson * 26 Herkimer * 25 Hamilton * 24 Greene * 23 Genesee * 22 Fulton * 21 Franklin * 20 Essex * 19 Erie 18 Dutchess * 17 Delaware * 16 Cortland * 15 Columbia * 14 Clinton * 13 ...

The 1996-2000 average annual age-adjusted incidence rate for invasive cancers of the liver and intrahepatic bile duct was almost three times higher in males than in females (6.8 compared to 2.4 per 100,000), and blacks of both sexes had higher rates compared to whites. There were 708 cases of liver /intrahepatic bile duct cancers diagnosed and reported among residents of Pennsylvania for 2000 – the highest annual figure recorded between 1991 and 2000. The annual age-adjusted incidence rates by sex and race for ten years (1991 through 2000) showed increasing rates among males, especially black males, and females of both races. The 1996-2000 average annual age-specific incidence rates show that black males have had the highest risks. During the period of 1996-2000, over 62 percent of the cases were diagnosed among residents 65 years of age or older. In 2000, over 57 percent of the staged liver /intrahepatic bile duct cancers were ...

A BASIC INFORMATION DESCRIPTION Uncontrolled growth of malignant cells in the liver . Liver cancer may be primarily resulting from abnormal liver or bile-duct cells, or it may result from spread of cancer from another site (metastases). The most com- mon sources are cancers of the rectum, colon, lung, breast, pancreas, esophagus or skin (malignant melanoma). Liver cancer can affect all ages, but is most common in men over 60. FREQUENT SIGNS AND SYMPTOMS • Loss of appetite and weight loss. • Tender mass in the right upper abdomen. • Pain in the upper abdomen. • Low fever, usually less than 101° F (38.3° C). • Yellow eyes and skin (sometimes). • Swollen abdomen from fluid retention (sometimes). • Lethargy. CAUSES Unknown. It occurs most often in population groups with a high incidence of viral hepatitis and other chronic liver ...

. cancer -- 5.1% . emphysema or chronic lung disease -- 5% . liver disease (cirrhosis, hepatitis, etc.) -- 2.7% . arthritis -- 2.3% . convulsions or seizures -- 1.6% . stroke or hemorrhage of the brain -- 1.5% . back problems -- 1.1% . HIV/AIDS -- 0.2% Other health problems were cited by 2% of respondents. Nearly 2/3 of adults (61%) reported at least one chronic or severe health problem. Thirty-five percent of adult respondents reported one category of problem or diagnostic category (see above); 15% reported two problem categories; 10% reported 3-4 such diagnostic categories, and 1%, 5 or more. Mental Health Symptoms Symptoms of anxiety and depression and experience of stress are prevalent among Tennessee adults. In the 30 days prior to the survey, 41% had been bothered by one or more of the following mental health symptoms described in the ...

1 Surgical Pathology Cancer Case Summary LIVER : Cytology/Biopsy Patient name: Cytology/Surgical pathology number: MACROSCOPIC (check all that apply) SPECIMEN TYPE Cytology (FNA) Needle biopsy Incisional biopsy TUMOR SITE Right lobe Left lobe Unknown Other ADEQUACY OF SPECIMEN (if applicable) Satisfactory Limited (see COMMENT) Unsatisfactory (see COMMENT) COMMENT _ _ _ _ MICROSCOPIC (check all that apply) HISTOLOGIC TYPE Cannot be assessed Hepatocellular carcinoma, NOS Fibrolamellar hepatocellular carcinoma Combined hepatocellular cholangiocarcinoma Cholangiocarcinoma Other (specify:) Page 2 2 HISTOLOGIC GRADE Not applicable GX: Cannot be assessed G1: Well differentiated G2: Moderately differentiated ...

liver cancer A LARGE LIVER - LIVER CANCER (Whole Class Session, Junior Clerkship 2002/2003) Learning Objectives To develop a clinical approach in the evaluation of a patient presenting with hepatomegaly To have a basic knowledge of the clinical features and management of common malignancies of the liver Hepatomegaly ?Differential Diagnosis Malignancy Primary liver malignancies Metastasis Haematological malignancies (lymphoma, leukaemia, myeloproliferative disease) Benign disease Benign neoplasms (haemangioma, adenoma, focal nodular hyperplasia) Cyst (simple cyst, polycystic disease) Alcoholic cirrhosis Others (e.g. liver abscess) Malignant Liver Tumours Primary: Hepatocellular carcinoma Cholangiocarcinoma ...

liver cancer A LARGE LIVER - LIVER CANCER (Whole Class Session, Junior Clerkship 2001/2002) Learning Objectives To develop a clinical approach in the evaluation of a patient presenting with hepatomegaly To have a basic knowledge of the clinical features and management of common malignancies of the liver Hepatomegaly ?Differential Diagnosis Malignancy Primary liver malignancies Metastasis Haematological malignancies (lymphoma, leukaemia, myeloproliferative disease) Benign disease Benign neoplasms (haemangioma, adenoma, focal nodular hyperplasia) Cyst (simple cyst, polycystic disease) Alcoholic cirrhosis Others (e.g. liver abscess) Malignant Liver Tumours Primary: Hepatocellular carcinoma Cholangiocarcinoma ...